Pharmaceutical Treatment of Dopamine Disorders

Conventional treatment of dopamine-related disorders pharmacologically adjusts dopamine without addressing diet, nutritional deficiencies, or pathway cofactors. Drug side effects from dopamine-targeting medications are documented, predictable consequences of treating a multi-system pathway molecule as a single isolated variable. Antipsychotic medications can cause Parkinson's-like motor symptoms by reducing dopamine in motor pathways. Parkinson's medications can trigger compulsive gambling by over-activating reward circuit dopamine. Anti-schizophrenia medications can cause motivational disorders and paranoia — the same symptom they are intended to treat.